Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse

Abstract

We assessed whether selective granulocyte and monocyte/macrophage adsorption apheresis maintained clinical remission in asymptomatic inflammatory bowel disease (IBD) patients at significant risk of clinical relapse.